![Karin Kleinhans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karin Kleinhans
Private Equity Investor bei Merck Research Ventures
Aktive Positionen von Karin Kleinhans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Merck Research Ventures
![]() Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.01.2002 | - |
Berlin Institute of Health | Berater | 01.01.2021 | - |
Karriereverlauf von Karin Kleinhans
Ehemalige bekannte Positionen von Karin Kleinhans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EQT Partners GmbH | Private Equity Investor | 01.01.2015 | 31.12.2022 |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Direktor/Vorstandsmitglied | 01.01.2017 | 31.12.2022 |
Arcum Therapeutics, Inc.
![]() Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcum Therapeutics, Inc. develops pharmaceutical drug products. It provides technologies aim at therapeutic intervention of multidrug-resistant bacterial infections. The company was founded by Paul M. Dunman and is headquartered in Pittsford, NY. | Direktor/Vorstandsmitglied | 01.01.2021 | 31.12.2022 |
LSP Services Deutschland GmbH | Private-Equity-Analyst | 01.01.2015 | 02.01.2022 |
T-Knife GmbH
![]() T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | 01.01.2021 | 31.12.2021 |
Ausbildung von Karin Kleinhans
Universität Ulm | Doctorate Degree |
Statistik
International
Deutschland | 7 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 3 |
Private Equity Investor | 2 |
Private Equity Analyst | 1 |
Sektoral
Finance | 4 |
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
LSP Services Deutschland GmbH | Finance |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
EQT Partners GmbH | Finance |
Merck Research Ventures
![]() Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Berlin Institute of Health | |
T-Knife GmbH
![]() T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Health Technology |
Arcum Therapeutics, Inc.
![]() Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcum Therapeutics, Inc. develops pharmaceutical drug products. It provides technologies aim at therapeutic intervention of multidrug-resistant bacterial infections. The company was founded by Paul M. Dunman and is headquartered in Pittsford, NY. | Health Technology |
- Börse
- Insiders
- Karin Kleinhans
- Erfahrung